Your browser doesn't support javascript.
loading
Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses.
Napolitani, Giorgio; Kurupati, Prathiba; Teng, Karen Wei Weng; Gibani, Malick M; Rei, Margarida; Aulicino, Anna; Preciado-Llanes, Lorena; Wong, Michael Thomas; Becht, Etienne; Howson, Lauren; de Haas, Paola; Salio, Mariolina; Blohmke, Christoph J; Olsen, Lars Rønn; Pinto, David Miguel Susano; Scifo, Laura; Jones, Claire; Dobinson, Hazel; Campbell, Danielle; Juel, Helene B; Thomaides-Brears, Helena; Pickard, Derek; Bumann, Dirk; Baker, Stephen; Dougan, Gordon; Simmons, Alison; Gordon, Melita A; Newell, Evan William; Pollard, Andrew J; Cerundolo, Vincenzo.
Afiliación
  • Napolitani G; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. giorgio.napolitani@imm.ox.ac.uk.
  • Kurupati P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Teng KWW; Singapore Immunology Network, Agency of Science, Technology and Research, Singapore, Singapore.
  • Gibani MM; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Rei M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Aulicino A; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Preciado-Llanes L; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Wong MT; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
  • Becht E; Singapore Immunology Network, Agency of Science, Technology and Research, Singapore, Singapore.
  • Howson L; Singapore Immunology Network, Agency of Science, Technology and Research, Singapore, Singapore.
  • de Haas P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Salio M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Blohmke CJ; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Olsen LR; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Pinto DMS; Department of Bio and Health Informatics, Technical University of Denmark, Copenhagen, Denmark.
  • Scifo L; Department of Biochemistry, Micron Oxford, University of Oxford, Oxford, UK.
  • Jones C; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Dobinson H; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Campbell D; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Juel HB; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Thomaides-Brears H; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Pickard D; Department of Paediatrics, Oxford Vaccine Group, University of Oxford and NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Bumann D; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Baker S; Biozentrum, University of Basel, Basel, Switzerland.
  • Dougan G; Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Simmons A; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Gordon MA; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Newell EW; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
  • Pollard AJ; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Cerundolo V; Singapore Immunology Network, Agency of Science, Technology and Research, Singapore, Singapore.
Nat Immunol ; 19(7): 742-754, 2018 07.
Article en En | MEDLINE | ID: mdl-29925993
ABSTRACT
To tackle the complexity of cross-reactive and pathogen-specific T cell responses against related Salmonella serovars, we used mass cytometry, unbiased single-cell cloning, live fluorescence barcoding, and T cell-receptor sequencing to reconstruct the Salmonella-specific repertoire of circulating effector CD4+ T cells, isolated from volunteers challenged with Salmonella enterica serovar Typhi (S. Typhi) or Salmonella Paratyphi A (S. Paratyphi). We describe the expansion of cross-reactive responses against distantly related Salmonella serovars and of clonotypes recognizing immunodominant antigens uniquely expressed by S. Typhi or S. Paratyphi A. In addition, single-amino acid variations in two immunodominant proteins, CdtB and PhoN, lead to the accumulation of T cells that do not cross-react against the different serovars, thus demonstrating how minor sequence variations in a complex microorganism shape the pathogen-specific T cell repertoire. Our results identify immune-dominant, serovar-specific, and cross-reactive T cell antigens, which should aid in the design of T cell-vaccination strategies against Salmonella.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_zoonosis Asunto principal: Salmonella paratyphi A / Salmonella typhi / Linfocitos T CD4-Positivos Límite: Adult / Humans Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_zoonosis Asunto principal: Salmonella paratyphi A / Salmonella typhi / Linfocitos T CD4-Positivos Límite: Adult / Humans Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
...